1 |
Burrow TA, Hopkin RJ, Leslie ND, Tinkle BT, Grabowski GA. Enzymereconstitution/replacement therapy fo rlysosomal storage disease. Current Opinion in Pediatrics 2007;19:628-35.
DOI
ScienceOn
|
2 |
Neufeld EF MJ. The mucopolysaccharidoses. In: Scriver CR, BeaudetAL, Sly WS, et al., editors. The metabolic and molecular bases of inherited disease. 8th Ed. New York: McGraw-Hill; 2001;3421-52.
|
3 |
Martin R, Beck M, Eng C, Giugliani R, Harmatz P, Munoz V, et al. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome). Pediatrics 2008;121:e377-86.
DOI
ScienceOn
|
4 |
Beebe RT, Formel PF. Gargoylism: sex-linked transmission in nine males. Trans Am Clin Climatol Assoc 1955;66:199-207.
|
5 |
Hunter C. A rare disease in two brothers. Proc R Soc Med. 1917;10:104-16.
|
6 |
Lin HY, Lin SP, Chuang CK, Niu DM, Chen MR, Tsai FJ, et al. Incidence of the mucopolysaccharidosis in Taiwan, 1984-2004. Am J Med Genet A 2009;149A:960-4.
DOI
ScienceOn
|
7 |
Cho SY, Jin DK. Distribution of Patients with Mucopolysaccharidosis in East Asia and Current Status and Prospect for Treatment. J Korean Soc Inherit Metab Dis 2013;13:81-8.
과학기술학회마을
|
8 |
Noh H, Lee JI. Current and potential therapeutic strategies for mucopolysaccharide. J Clin Pharm Ther 2014;39:215-24.
DOI
ScienceOn
|
9 |
Young ID, Harper PS. Mild form of Hunter's syndrome: clinical delineation based on 31 cases. Arch Dis Child 1982;57:828-36.
DOI
|
10 |
Burton BK, Giugliani R. Diagnosing Hunter syndrome in pediatric practice: practical considerations and common pitfalls. Eur J Pediatr 2012;171:631-9.
DOI
|
11 |
Sohn YB, Cho SY, Park SW, et al. Phase I/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (Hunter syndrome). Orphanet J Rare Dis 2013;8:42.
DOI
|
12 |
Muenzer J. Early initiation of enzyme replacement therapy for the mucopolysaccharidosis. Mol Genet Metab 201;111:63-72.
DOI
|
13 |
Giugliani R, Hwu WL, Tylki-Szymanska A, Whiterman DA, Pano A. A multicenter, open-label study evaluation safety and clinical outcomes in children (1.4-7.5 years) with Hunter syndrome receiving idursulfase enzyme replacement therapy. Genet Med 2014;16:435-41.
DOI
ScienceOn
|
14 |
Wraith JE, Beck M, Giugliani R, Clarke J, Martin R, Muenzer J. Initial report from the Hunter Outcome Survey. Genet Med. 2008;10:508-16.
DOI
ScienceOn
|
15 |
Park SW, Sohn YB, Kim SH, et al. Enzyme replacement therapy in patients who have mucopolysaccharidosis and are younger than 5 years old. J Korean Soc Inherit Metab Dis 2010;10:59-66.
과학기술학회마을
|